(Q53441538)

14 May 2018

title

The molecular anatomy of the FIP1L1-PDGFRA fusion gene. (English)

1 reference

14 May 2018

author

Andreas Hochhaus

10

1 reference

14 May 2018

Giuseppe Saglio

16

1 reference

14 May 2018

Nicholas Cross

17

1 reference

14 May 2018

Catherine Roche-Lestienne

object named as

C Roche-Lestienne

5

0 references

Claude Preudhomme

object named as

C Preudhomme

13

0 references

author name string

C Walz

1

1 reference

14 May 2018

J Score

2

1 reference

14 May 2018

J Mix

3

1 reference

14 May 2018

D Cilloni

4

1 reference

14 May 2018

R-F Yeh

6

1 reference

14 May 2018

J L Wiemels

7

1 reference

14 May 2018

E Ottaviani

8

1 reference

14 May 2018

P Erben

9

1 reference

14 May 2018

M Baccarani

11

1 reference

14 May 2018

D Grimwade

12

1 reference

14 May 2018

J Apperley

14

1 reference

14 May 2018

G Martinelli

15

1 reference

14 May 2018

A Reiter

18

1 reference

14 May 2018

European LeukemiaNet

19

1 reference

14 May 2018

publication date

6 November 2008

1 reference

14 May 2018

published in

Leukemia

1 reference

14 May 2018

volume

23

1 reference

14 May 2018

issue

2

1 reference

14 May 2018

page(s)

271-278

1 reference

14 May 2018

https://scigraph.springernature.com/pub.10.1038/leu.2008.310

exact match

0 references

cites work

Mechanism of DNA double-strand break repair by non-homologous end joining

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.310

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.310

7 January 2021

Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.310

7 January 2021

CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.310

7 January 2021

FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.310

7 January 2021

Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.310

7 January 2021

The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.310

7 January 2021

Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.310

7 January 2021

Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome: a phase-II study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.310

7 January 2021

Identification of a novel imatinib responsive KIF5B-PDGFRA fusion gene following screening for PDGFRA overexpression in patients with hypereosinophilia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.310

7 January 2021

Evaluation of sequence motifs found in scaffold/matrix-attached regions (S/MARs)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.310

7 January 2021

The t(4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRA.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.310

7 January 2021

Two novel imatinib-responsive PDGFRA fusion genes in chronic eosinophilic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.310

7 January 2021

Transient response to imatinib in a chronic eosinophilic leukemia associated with ins(9;4)(q33;q12q25) and a CDK5RAP2-PDGFRA fusion gene.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.310

7 January 2021

Activation of FIP1L1-PDGFRalpha requires disruption of the juxtamembrane domain of PDGFRalpha and is FIP1L1-independent

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.310

7 January 2021

The seventh pathogenic fusion gene FIP1L1-RARA was isolated from a t(4;17)-positive acute promyelocytic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.310

7 January 2021

Making ends meet: repairing breaks in bacterial DNA by non-homologous end-joining

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.310

7 January 2021

Microclustering of TEL-AML1 translocation breakpoints in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.310

7 January 2021

A DNA damage repair mechanism is involved in the origin of chromosomal translocations t(4;11) in primary leukemic cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.310

7 January 2021

Fine structure of translocation breakpoints in leukemic blasts with chromosomal translocation t(4;11): the DNA damage-repair model of translocation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.310

7 January 2021

NUP98 is fused to topoisomerase (DNA) IIbeta 180 kDa (TOP2B) in a patient with acute myeloid leukemia with a new t(3;11)(p24;p15).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.310

7 January 2021

Genomic anatomy of the specific reciprocal translocation t(15;17) in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.310

7 January 2021

Genomic acute myeloid leukemia-associated inv(16)(p13q22) breakpoints are tightly clustered

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.310

7 January 2021

Molecular characterization of genomic AML1-ETO fusions in childhood leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.310

7 January 2021

Characterization of genomic BCR-ABL breakpoints in chronic myeloid leukaemia by PCR.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.310

7 January 2021

Identifiers

DOI

10.1038/LEU.2008.310

1 reference

14 May 2018

Dimensions Publication ID

1042163968

0 references

1 reference

14 May 2018